Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?

An analysis from the percutaneous stem cell injection delivery effects on neomyogenesis (POSEIDON) randomized trial

Viky Y. Suncion, Eduard Ghersin, Joel E. Fishman, Juan Pablo Zambrano, Vasileios Karantalis, Nicole Mandel, Katarina H. Nelson, Gary Gerstenblith, Darcy L. Difede Velazquez, Elayne Breton, Kranthi Sitammagari, Ivonne H. Schulman, Sabrina N. Taldone, Adam R. Williams, Cristina Sanina, Peter V Johnston, Jeffrey A Brinker, Peter Altman, Muzammil Mushtaq, Barry Trachtenberg & 8 others Adam M. Mendizabal, Melissa Tracy, Jose Da Silva, Ian K. McNiece, Alberto C. Lardo, Richard T. George, Joshua M. Hare, Alan W. Heldman

Research output: Contribution to journalArticle

Abstract

Rationale: Transendocardial stem cell injection (TESI) with mesenchymal stem cells improves remodeling in chronic ischemic cardiomyopathy, but the effect of the injection site remains unknown. Objective: To address whether TESI exerts its effects at the site of injection only or also in remote areas, we hypothesized that segmental myocardial scar and segmental ejection fraction improve to a greater extent in injected than in noninjected segments. Methods and results: Biplane ventriculographic and endocardial tracings were recorded. TESI was guided to 10 sites in infarct-border zones. Sites were mapped according to the 17-myocardial segment model. As a result, 510 segments were analyzed in 30 patients before and 13 months after TESI. Segmental early enhancement defect (a measure of scar size) was reduced by TESI in both injected (-43.7±4.4%; n=95; P

Original languageEnglish (US)
Pages (from-to)1292-1301
Number of pages10
JournalCirculation Research
Volume114
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Mesenchymal Stromal Cells
Stem Cells
Injections
Cicatrix
Cardiomyopathies

Keywords

  • cells
  • magnetic resonance imaging
  • myocardial infarction
  • tomography

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally? An analysis from the percutaneous stem cell injection delivery effects on neomyogenesis (POSEIDON) randomized trial. / Suncion, Viky Y.; Ghersin, Eduard; Fishman, Joel E.; Zambrano, Juan Pablo; Karantalis, Vasileios; Mandel, Nicole; Nelson, Katarina H.; Gerstenblith, Gary; Difede Velazquez, Darcy L.; Breton, Elayne; Sitammagari, Kranthi; Schulman, Ivonne H.; Taldone, Sabrina N.; Williams, Adam R.; Sanina, Cristina; Johnston, Peter V; Brinker, Jeffrey A; Altman, Peter; Mushtaq, Muzammil; Trachtenberg, Barry; Mendizabal, Adam M.; Tracy, Melissa; Da Silva, Jose; McNiece, Ian K.; Lardo, Alberto C.; George, Richard T.; Hare, Joshua M.; Heldman, Alan W.

In: Circulation Research, Vol. 114, No. 8, 2014, p. 1292-1301.

Research output: Contribution to journalArticle

Suncion, VY, Ghersin, E, Fishman, JE, Zambrano, JP, Karantalis, V, Mandel, N, Nelson, KH, Gerstenblith, G, Difede Velazquez, DL, Breton, E, Sitammagari, K, Schulman, IH, Taldone, SN, Williams, AR, Sanina, C, Johnston, PV, Brinker, JA, Altman, P, Mushtaq, M, Trachtenberg, B, Mendizabal, AM, Tracy, M, Da Silva, J, McNiece, IK, Lardo, AC, George, RT, Hare, JM & Heldman, AW 2014, 'Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally? An analysis from the percutaneous stem cell injection delivery effects on neomyogenesis (POSEIDON) randomized trial', Circulation Research, vol. 114, no. 8, pp. 1292-1301. https://doi.org/10.1161/CIRCRESAHA.114.302854
Suncion, Viky Y. ; Ghersin, Eduard ; Fishman, Joel E. ; Zambrano, Juan Pablo ; Karantalis, Vasileios ; Mandel, Nicole ; Nelson, Katarina H. ; Gerstenblith, Gary ; Difede Velazquez, Darcy L. ; Breton, Elayne ; Sitammagari, Kranthi ; Schulman, Ivonne H. ; Taldone, Sabrina N. ; Williams, Adam R. ; Sanina, Cristina ; Johnston, Peter V ; Brinker, Jeffrey A ; Altman, Peter ; Mushtaq, Muzammil ; Trachtenberg, Barry ; Mendizabal, Adam M. ; Tracy, Melissa ; Da Silva, Jose ; McNiece, Ian K. ; Lardo, Alberto C. ; George, Richard T. ; Hare, Joshua M. ; Heldman, Alan W. / Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally? An analysis from the percutaneous stem cell injection delivery effects on neomyogenesis (POSEIDON) randomized trial. In: Circulation Research. 2014 ; Vol. 114, No. 8. pp. 1292-1301.
@article{d446baa311384f36bfdd46c76902b757,
title = "Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the percutaneous stem cell injection delivery effects on neomyogenesis (POSEIDON) randomized trial",
abstract = "Rationale: Transendocardial stem cell injection (TESI) with mesenchymal stem cells improves remodeling in chronic ischemic cardiomyopathy, but the effect of the injection site remains unknown. Objective: To address whether TESI exerts its effects at the site of injection only or also in remote areas, we hypothesized that segmental myocardial scar and segmental ejection fraction improve to a greater extent in injected than in noninjected segments. Methods and results: Biplane ventriculographic and endocardial tracings were recorded. TESI was guided to 10 sites in infarct-border zones. Sites were mapped according to the 17-myocardial segment model. As a result, 510 segments were analyzed in 30 patients before and 13 months after TESI. Segmental early enhancement defect (a measure of scar size) was reduced by TESI in both injected (-43.7±4.4{\%}; n=95; P",
keywords = "cells, magnetic resonance imaging, myocardial infarction, tomography",
author = "Suncion, {Viky Y.} and Eduard Ghersin and Fishman, {Joel E.} and Zambrano, {Juan Pablo} and Vasileios Karantalis and Nicole Mandel and Nelson, {Katarina H.} and Gary Gerstenblith and {Difede Velazquez}, {Darcy L.} and Elayne Breton and Kranthi Sitammagari and Schulman, {Ivonne H.} and Taldone, {Sabrina N.} and Williams, {Adam R.} and Cristina Sanina and Johnston, {Peter V} and Brinker, {Jeffrey A} and Peter Altman and Muzammil Mushtaq and Barry Trachtenberg and Mendizabal, {Adam M.} and Melissa Tracy and {Da Silva}, Jose and McNiece, {Ian K.} and Lardo, {Alberto C.} and George, {Richard T.} and Hare, {Joshua M.} and Heldman, {Alan W.}",
year = "2014",
doi = "10.1161/CIRCRESAHA.114.302854",
language = "English (US)",
volume = "114",
pages = "1292--1301",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?

T2 - An analysis from the percutaneous stem cell injection delivery effects on neomyogenesis (POSEIDON) randomized trial

AU - Suncion, Viky Y.

AU - Ghersin, Eduard

AU - Fishman, Joel E.

AU - Zambrano, Juan Pablo

AU - Karantalis, Vasileios

AU - Mandel, Nicole

AU - Nelson, Katarina H.

AU - Gerstenblith, Gary

AU - Difede Velazquez, Darcy L.

AU - Breton, Elayne

AU - Sitammagari, Kranthi

AU - Schulman, Ivonne H.

AU - Taldone, Sabrina N.

AU - Williams, Adam R.

AU - Sanina, Cristina

AU - Johnston, Peter V

AU - Brinker, Jeffrey A

AU - Altman, Peter

AU - Mushtaq, Muzammil

AU - Trachtenberg, Barry

AU - Mendizabal, Adam M.

AU - Tracy, Melissa

AU - Da Silva, Jose

AU - McNiece, Ian K.

AU - Lardo, Alberto C.

AU - George, Richard T.

AU - Hare, Joshua M.

AU - Heldman, Alan W.

PY - 2014

Y1 - 2014

N2 - Rationale: Transendocardial stem cell injection (TESI) with mesenchymal stem cells improves remodeling in chronic ischemic cardiomyopathy, but the effect of the injection site remains unknown. Objective: To address whether TESI exerts its effects at the site of injection only or also in remote areas, we hypothesized that segmental myocardial scar and segmental ejection fraction improve to a greater extent in injected than in noninjected segments. Methods and results: Biplane ventriculographic and endocardial tracings were recorded. TESI was guided to 10 sites in infarct-border zones. Sites were mapped according to the 17-myocardial segment model. As a result, 510 segments were analyzed in 30 patients before and 13 months after TESI. Segmental early enhancement defect (a measure of scar size) was reduced by TESI in both injected (-43.7±4.4%; n=95; P

AB - Rationale: Transendocardial stem cell injection (TESI) with mesenchymal stem cells improves remodeling in chronic ischemic cardiomyopathy, but the effect of the injection site remains unknown. Objective: To address whether TESI exerts its effects at the site of injection only or also in remote areas, we hypothesized that segmental myocardial scar and segmental ejection fraction improve to a greater extent in injected than in noninjected segments. Methods and results: Biplane ventriculographic and endocardial tracings were recorded. TESI was guided to 10 sites in infarct-border zones. Sites were mapped according to the 17-myocardial segment model. As a result, 510 segments were analyzed in 30 patients before and 13 months after TESI. Segmental early enhancement defect (a measure of scar size) was reduced by TESI in both injected (-43.7±4.4%; n=95; P

KW - cells

KW - magnetic resonance imaging

KW - myocardial infarction

KW - tomography

UR - http://www.scopus.com/inward/record.url?scp=84898892501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898892501&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.114.302854

DO - 10.1161/CIRCRESAHA.114.302854

M3 - Article

VL - 114

SP - 1292

EP - 1301

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 8

ER -